Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Moore

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Biochemistry|August 19, 2007
Structural and functional characterization of CC chemokine CCL14Katherine Y Blain, Witek Kwiatkowski, Qinghai Zhao, et al.
Arthritis and Rheumatism|May 28, 2010
Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffoldMaria-Concetta Veri, Stephen Burke, Ling Huang, et al.
Blood|November 5, 2015
Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platformMuneera Al-Hussaini, Michael P Rettig, Julie K Ritchey, et al.
Journal of the American Dental Association (1939)|July 27, 2023
Corticosteroids for managing acute pain subsequent to surgical extraction of mandibular third molars: A systematic review and meta-analysisAnna Miroshnychenko, Maria Azab, Sara Ibrahim, et al.
Cancer Letters|February 16, 2024
Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinomaGiulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell MalignanciesLiqin Liu, Chia-Ying K Lam, Vatana Long, et al.
Antibodies (Basel, Switzerland)|January 23, 2025
A Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART<sup>®</sup> Molecule for Treatment of Solid TumorsRenhua R Huang, Michael Spliedt, Tom Kaufman, et al.
Blood|February 9, 2011
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphomaPaul A Moore, Wenjun Zhang, G Jonah Rainey, et al.
Cell Reports. Medicine|December 30, 2020
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART MoleculeAlexey Berezhnoy, Bradley J Sumrow, Kurt Stahl, et al.
Journal of the American Dental Association (1939)|May 2, 2013
An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothaches: efficacy, tolerability and compliance with label dose administration directionsElliot V Hersh, Sebastian G Ciancio, Arthur S Kuperstein, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Biochemistry|August 19, 2007
Structural and functional characterization of CC chemokine CCL14Katherine Y Blain, Witek Kwiatkowski, Qinghai Zhao, et al.
Arthritis and Rheumatism|May 28, 2010
Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffoldMaria-Concetta Veri, Stephen Burke, Ling Huang, et al.
Blood|November 5, 2015
Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platformMuneera Al-Hussaini, Michael P Rettig, Julie K Ritchey, et al.
Journal of the American Dental Association (1939)|July 27, 2023
Corticosteroids for managing acute pain subsequent to surgical extraction of mandibular third molars: A systematic review and meta-analysisAnna Miroshnychenko, Maria Azab, Sara Ibrahim, et al.
Cancer Letters|February 16, 2024
Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinomaGiulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell MalignanciesLiqin Liu, Chia-Ying K Lam, Vatana Long, et al.
Antibodies (Basel, Switzerland)|January 23, 2025
A Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART<sup>®</sup> Molecule for Treatment of Solid TumorsRenhua R Huang, Michael Spliedt, Tom Kaufman, et al.
Blood|February 9, 2011
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphomaPaul A Moore, Wenjun Zhang, G Jonah Rainey, et al.
Cell Reports. Medicine|December 30, 2020
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART MoleculeAlexey Berezhnoy, Bradley J Sumrow, Kurt Stahl, et al.
Journal of the American Dental Association (1939)|May 2, 2013
An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothaches: efficacy, tolerability and compliance with label dose administration directionsElliot V Hersh, Sebastian G Ciancio, Arthur S Kuperstein, et al.
Pageof 15